Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

3.680

-0.410 (-10.02%)

At close: May 13, 2026, 4:00 PM EDT

3.820

+0.140 (3.80%)

After-hours: May 13, 2026, 7:11 PM EDT

Ironwood Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	102.18	24.02	0.88	-1,032	175.07	528.45
Depreciation & Amortization	1.85	1.88	2.01	1.58	1.42	1.52
Stock-Based Compensation	15.61	17.25	29.85	32.01	27.05	22.28
Other Adjustments	62.77	44.25	71.63	1,170	67.41	-310.09
Change in Receivables	-66.07	35.15	47.24	0.92	7.99	7.71
Changes in Accounts Payable	-8.35	6.2	-20.21	12.58	-1.12	-2.64
Changes in Accrued Expenses	-4.15	-4.11	-14.65	-5.88	-10.64	14
Changes in Other Operating Activities	8.34	2.41	-13.2	3.85	14.46	-1.46
Operating Cash Flow	112.21	127.04	103.55	183.43	273.76	261.9
Operating Cash Flow Growth	42.91%	22.69%	-43.55%	-33.00%	4.53%	55.12%
Capital Expenditures	-0	-0.03	-0.14	-0.27	-0.14	-0.27
Payments for Business Acquisitions	-	-	-	-1,026	-	-
Investing Cash Flow	-0	-0.03	-0.14	-1,026	-0.14	-0.27
Short-Term Debt Issued	-	-	150	400	-	-
Short-Term Debt Repaid	-	-	-65	-100	-	-
Net Short-Term Debt Issued (Repaid)	-	-	85	300	-	-
Long-Term Debt Repaid	-	-	-200	-	-120.7	-
Net Long-Term Debt Issued (Repaid)	-	-	-200	-	-120.7	-
Issuance of Common Stock	0.21	0.22	11.01	6.36	9.54	19.58
Repurchase of Common Stock	-	-	-0.74	-	-126.39	-24.13
Net Common Stock Issued (Repurchased)	0.21	0.22	10.28	6.36	-116.85	-4.55
Other Financing Activities	-	-	-2.25	-29.2	-	-
Financing Cash Flow	0.21	0.22	-106.97	277.16	-237.55	-4.55
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.43	-0.33	-0.03	-0.05	-	-
Net Cash Flow	111.99	126.9	-3.6	-565.78	36.07	257.08
Free Cash Flow	112.21	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Growth	-11.65%	22.82%	-43.54%	-33.06%	4.58%	56.67%
FCF Margin	31.04%	42.89%	29.43%	41.37%	66.64%	63.23%
Free Cash Flow Per Share	0.66	0.78	0.65	1.18	1.47	1.59
Levered Free Cash Flow	99.85	30.37	-160.31	-1,722	233.42	1,068
Unlevered Free Cash Flow	278.76	169.57	138.81	-850.32	331.04	-136

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q